OESIL Score for Syncope

The OESIL Score predicts short‑term mortality risk in syncope patients using four clinical variables.

Age > 65 years
No0Yes+1
CVD in clinical history (structure HD, CHF, PAD, stroke/TIA)
No0Yes+1
Syncope without prodrome
No0Yes+1
Abnormal EKG
No0Yes+1

Indications for Use

Used in adults with unexplained syncope after initial ED evaluation to estimate short‑term (30‑day) mortality risk, guiding decisions on admission vs. discharge. Derived/validated in ED cohorts; higher scores correlate with increased mortality (sensitivity 95%, specificity 31%) 1 [Level II evidence]; meta‑analysis confirms modest prognostic accuracy compared with other tools 2 [Level II evidence].

Insights & Cautions

Identifies short‑term mortality risk using four items (age > 65, abnormal ECG, history of heart disease, no prodrome). Mortality rises with accumulating points, but accuracy is limited: pooled sensitivity ~95% and specificity ~31% in validation studies (meta‑analysis, 5 studies) 1 [Level II evidence]. International comparison shows inferior discrimination vs CSRS (AUC 0.74 vs 0.85) 2 [Level II evidence]. Use cautiously—overestimates risk and performs worse than structured clinical judgment.